Proyecto Informar: Food and Drug Administration Hispanic Outreach Initiative (U01), 37820-37821 [2011-16091]
Download as PDF
<![CDATA[
37820
Federal Register / Vol. 76, No. 124 / Tuesday, June 28, 2011 / Notices
I. Funding Opportunity Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0012]
Proyecto Informar: Food and Drug
Administration Hispanic Outreach
Initiative (U01)
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of grant funds for the
support of a cooperative agreement for
the National Alliance for Hispanic
Health. The goal of the Food and Drug
Administration, Office of the
Commissioner, is to support initiatives
that will communicate risk and
emergency public health information to
millions of Spanish-speaking consumers
within the targeted populations (socially
disadvantaged, underserved
populations, ethnic and racial
populations, health professionals,
patients and caregivers, pediatrics,
adolescents, and disabled and older
Americans).
SUMMARY:
Important dates are as follows:
1. The application due date is July 15,
2011.
2. The anticipated start date is in
September 2011.
3. The opening date is June 28, 2011.
4. The expiration date is July 16,
2011.
DATES:
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION AND
ADDITIONAL REQUIREMENTS CONTACT:
For programmatic questions and
concerns: Mary Hitch, Office of External
Relations, Office of the Commissioner,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, rm.
5320, Silver Spring, MD 20993–0002,
301–796–8639, e-mail:
mary.hitch@fda.hhs.gov.
For financial and administrative
questions or concerns: Gladys M.
Melendez, Office of Acquisition and
Grant Services, Food and Drug
Administration, 5630 Fishers Lane
(HFA–500), Rockville, MD 20857, 301–
827–7175, e-mail:
gladys.bohler@fda.hhs.gov.
For more information on this funding
opportunity announcement (FOA) and
to obtain detailed requirements, and a
copy of the full FOA, please contact the
programmatic or grants contact noted in
this section.
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
16:46 Jun 27, 2011
Jkt 223001
A. Background
FDA announces its intent to accept a
single source application for awarding
of a Cooperative Agreement to the
National Alliance for Hispanic Health
(The Alliance). The purpose of this
agreement is to support initiatives that
will communicate risk and emergency
public health information to millions of
Spanish-speaking consumers within the
targeted populations (socially
disadvantaged, underserved
populations, ethnic and racial
populations, health professionals,
patients and caregivers, pediatrics,
adolescents, and disabled and older
Americans). FDA authority to enter
grants and cooperative agreements is set
out in section 1704 of the Public Health
Service Act (42 U.S.C. 300u–3).
FDA relies on community
partnerships to enhance its efforts in
risk and emergency communications
about the appropriate use of FDAregulated products and to assure
targeted communities understand their
roles in managing the risks of using
FDA-regulated products. Through this
initiative, FDA also seeks to share risk
and benefit information to enable
people to decide how to use FDAregulated products, to provide access to
critical risk and benefit information that
is adapted to their specific needs—
when, where, and in the form they need
to best understand and apply this
information, regarding literacy,
language, culture, race and ethnicity,
and disability.
This program may support a wide
range of appropriate innovative
education and outreach activities and
tools in risk communications. FDA must
work with partners to continuously
develop and disseminate
communications rapidly and to develop
and test messages on the appropriate
use of FDA-regulated products.
B. Research Objectives
The goal of the program is to assure
effective and efficient communications
to meet the need for adapted risk
communications based on literacy,
Spanish language, culture, race/
ethnicity, disability, and other factors
during emergency events, such as
recalls of FDA-regulated products such
as food, drugs, cosmetics, and medical
devices. The applicant must identify
specific ways in which FDA could have
substantial involvement in the proposed
program. The applicant must suggest
activities that would contribute directly
to the purpose of the program. For any
additional initiatives suggested, the
applicant should identify the objective
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
of the activity, the specific tasks
required to meet the objective, specific
timelines for performing the tasks, and
specific initiatives to achieve the
purpose and goal of this program. The
recipient will be required to perform the
following initiatives:
Develop and finalize a risk
communication and public heath alert
delivery plan that will contain the tasks
needed to accomplish the purpose of
this program, including a description of
the various tasks for the project that will
be completed, the dates by which each
task be completed, and who will have
responsibility for each task. Task
milestones must be listed to assure that
progress can be measured at various
dates through the life of the project and
document all risk communications and
public health alert activities to be
conducted under the agreement and the
results of such activities, including
criteria and indicators used to evaluate
the success of the program.
The plan must delineate the
substantial involvement of FDA.
C. Eligibility Information
• National Alliance for Hispanic
Health.
Before entering cooperative
agreements, FDA carefully considers the
benefits such agreements will provide to
the public. The Alliance, a nonprofit
entity as described in section 501(c) 3 of
the Internal Revenue Code of 1968, is
the oldest and largest network of
Hispanic health and human service
providers for the target population. The
Alliance is an umbrella organization
that serves more than 400 national and
community-based organizations and
other health professionals who provide
access and delivery of quality health
and human services to some 46.9
million Hispanic health consumers.
The Alliance is a recognized leader
within Hispanic communities and
works with foundations, corporations,
Government Agencies, universities, and
private industry in carrying out its
mission, with the objective of improving
the health status of Hispanic and
minority populations.
II. Award Information/Funds Available
A. Award Amount
Only one grant will be awarded. FDA
will award $35,000. Partnering Federal
Agencies may commit up to an
estimated total of $500,000 in cofunding
or supplemental funds for program
expansion, pending the availability of
funds.
B. Length of Support
The project will be funded for up to
3 years from the starting date for
E:\FR\FM\28JNN1.SGM
28JNN1
37821
Federal Register / Vol. 76, No. 124 / Tuesday, June 28, 2011 / Notices
activities described in this
announcement. Continuation of support
beyond the first year will be based on
satisfactory performance during the
preceding year, receipt of a
noncompeting continuation application,
and available Federal fiscal year funds.
III. Paper Application, Registration,
and Submission Information
To submit a paper application in
response to this FOA, applicants should
first review the full announcement
available through the programmatic or
grants contact noted earlier in this
document. (See For Further Information
and Additional Requirements Contact).
Persons interested in applying for a
grant may obtain an application at
https://grants2.nih.gov/grants/funding/
phs398/phs398.html. For all paper
application submissions, the following
steps are required:
• Step 1: Obtain a Dun and Bradstreet
Data Universal Numbering System
(DUNS) Number.
• Step 2: Register With Central
Contractor Registration.
• Step 3: Register With Electronic
Research Administration (eRA)
Commons.
Steps 1 and 2, in detail, can be found
at https://www07.grants.gov/applicants/
organization_registration.jsp. Step 3, in
detail, can be found at https://
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit paper applications to: Gladys M.
Melendez, Grants Management Officer/
Specialist at the address noted earlier in
this document (See For Further
Information and Additional
Requirements Contact).
Dated: June 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–16091 Filed 6–27–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Number of
respondents
Respondents
Proposed Project: Poison Help General
Population Survey (OMB No. 0915–
XXXX)—[NEW]
Annually, in the U.S., poison control
centers (PCCs) manage over 4.2 million
calls, providing ready and direct access
to vital public health emergency
information and response. In 2001, the
Poison Help line, a single, national tollfree number (800–222–1222) was
established to ensure universal access to
PCC services, 24 hours a day, seven
days a week. The Poison Help campaign
is the only national media effort to
promote awareness and use of the
national toll-free number. The Poison
Help campaign aims to reach a wide
audience, as individuals of all ages are
at risk for poisoning and may need to
access PCC services. The Poison Help
General Population Survey will be
conducted with 2,000 households in the
United States to evaluate the campaign’s
current performance. The survey
supplies unique and essential
information that provides HRSA with
data related to national toll-free number.
The survey will address topics related to
the types of individuals and/or
organizations respondents would
contact for information, advice, and
treatment related to poisoning, as well
as poison prevention. Survey results
will be used to guide future
communication, education, and
outreach efforts. There is no cost to
respondents.
The annual estimate of burden is as
follows:
Number of
responses/
respondent
Average hours
per response
Total burden
hours
Survey respondents .........................................................................................
Screened households ......................................................................................
2000
2353
1
1
.166
.016
332
38
Total ..........................................................................................................
4353
........................
........................
370
mstockstill on DSK4VPTVN1PROD with NOTICES
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
e-mail to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: June 21, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–16127 Filed 6–27–11; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
16:46 Jun 27, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute of Child Health and Human
Development, Special Emphasis Panel,
‘‘PED/PHARM’’.
Date: July 12–13, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 76, Number 124 (Tuesday, June 28, 2011)]
[Notices]
[Pages 37820-37821]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16091]
[[Page 37820]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0012]
Proyecto Informar: Food and Drug Administration Hispanic Outreach
Initiative (U01)
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of grant funds for the support of a cooperative agreement
for the National Alliance for Hispanic Health. The goal of the Food and
Drug Administration, Office of the Commissioner, is to support
initiatives that will communicate risk and emergency public health
information to millions of Spanish-speaking consumers within the
targeted populations (socially disadvantaged, underserved populations,
ethnic and racial populations, health professionals, patients and
caregivers, pediatrics, adolescents, and disabled and older Americans).
DATES: Important dates are as follows:
1. The application due date is July 15, 2011.
2. The anticipated start date is in September 2011.
3. The opening date is June 28, 2011.
4. The expiration date is July 16, 2011.
FOR FURTHER INFORMATION AND ADDITIONAL REQUIREMENTS CONTACT:
For programmatic questions and concerns: Mary Hitch, Office of
External Relations, Office of the Commissioner, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5320, Silver
Spring, MD 20993-0002, 301-796-8639, e-mail: mary.hitch@fda.hhs.gov.
For financial and administrative questions or concerns: Gladys M.
Melendez, Office of Acquisition and Grant Services, Food and Drug
Administration, 5630 Fishers Lane (HFA-500), Rockville, MD 20857, 301-
827-7175, e-mail: gladys.bohler@fda.hhs.gov.
For more information on this funding opportunity announcement (FOA)
and to obtain detailed requirements, and a copy of the full FOA, please
contact the programmatic or grants contact noted in this section.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
A. Background
FDA announces its intent to accept a single source application for
awarding of a Cooperative Agreement to the National Alliance for
Hispanic Health (The Alliance). The purpose of this agreement is to
support initiatives that will communicate risk and emergency public
health information to millions of Spanish-speaking consumers within the
targeted populations (socially disadvantaged, underserved populations,
ethnic and racial populations, health professionals, patients and
caregivers, pediatrics, adolescents, and disabled and older Americans).
FDA authority to enter grants and cooperative agreements is set out in
section 1704 of the Public Health Service Act (42 U.S.C. 300u-3).
FDA relies on community partnerships to enhance its efforts in risk
and emergency communications about the appropriate use of FDA-regulated
products and to assure targeted communities understand their roles in
managing the risks of using FDA-regulated products. Through this
initiative, FDA also seeks to share risk and benefit information to
enable people to decide how to use FDA-regulated products, to provide
access to critical risk and benefit information that is adapted to
their specific needs--when, where, and in the form they need to best
understand and apply this information, regarding literacy, language,
culture, race and ethnicity, and disability.
This program may support a wide range of appropriate innovative
education and outreach activities and tools in risk communications. FDA
must work with partners to continuously develop and disseminate
communications rapidly and to develop and test messages on the
appropriate use of FDA-regulated products.
B. Research Objectives
The goal of the program is to assure effective and efficient
communications to meet the need for adapted risk communications based
on literacy, Spanish language, culture, race/ethnicity, disability, and
other factors during emergency events, such as recalls of FDA-regulated
products such as food, drugs, cosmetics, and medical devices. The
applicant must identify specific ways in which FDA could have
substantial involvement in the proposed program. The applicant must
suggest activities that would contribute directly to the purpose of the
program. For any additional initiatives suggested, the applicant should
identify the objective of the activity, the specific tasks required to
meet the objective, specific timelines for performing the tasks, and
specific initiatives to achieve the purpose and goal of this program.
The recipient will be required to perform the following initiatives:
Develop and finalize a risk communication and public heath alert
delivery plan that will contain the tasks needed to accomplish the
purpose of this program, including a description of the various tasks
for the project that will be completed, the dates by which each task be
completed, and who will have responsibility for each task. Task
milestones must be listed to assure that progress can be measured at
various dates through the life of the project and document all risk
communications and public health alert activities to be conducted under
the agreement and the results of such activities, including criteria
and indicators used to evaluate the success of the program.
The plan must delineate the substantial involvement of FDA.
C. Eligibility Information
National Alliance for Hispanic Health.
Before entering cooperative agreements, FDA carefully considers the
benefits such agreements will provide to the public. The Alliance, a
nonprofit entity as described in section 501(c) 3 of the Internal
Revenue Code of 1968, is the oldest and largest network of Hispanic
health and human service providers for the target population. The
Alliance is an umbrella organization that serves more than 400 national
and community-based organizations and other health professionals who
provide access and delivery of quality health and human services to
some 46.9 million Hispanic health consumers.
The Alliance is a recognized leader within Hispanic communities and
works with foundations, corporations, Government Agencies,
universities, and private industry in carrying out its mission, with
the objective of improving the health status of Hispanic and minority
populations.
II. Award Information/Funds Available
A. Award Amount
Only one grant will be awarded. FDA will award $35,000. Partnering
Federal Agencies may commit up to an estimated total of $500,000 in
cofunding or supplemental funds for program expansion, pending the
availability of funds.
B. Length of Support
The project will be funded for up to 3 years from the starting date
for
[[Page 37821]]
activities described in this announcement. Continuation of support
beyond the first year will be based on satisfactory performance during
the preceding year, receipt of a noncompeting continuation application,
and available Federal fiscal year funds.
III. Paper Application, Registration, and Submission Information
To submit a paper application in response to this FOA, applicants
should first review the full announcement available through the
programmatic or grants contact noted earlier in this document. (See For
Further Information and Additional Requirements Contact). Persons
interested in applying for a grant may obtain an application at https://grants2.nih.gov/grants/funding/phs398/phs398.html. For all paper
application submissions, the following steps are required:
Step 1: Obtain a Dun and Bradstreet Data Universal
Numbering System (DUNS) Number.
Step 2: Register With Central Contractor Registration.
Step 3: Register With Electronic Research Administration
(eRA) Commons.
Steps 1 and 2, in detail, can be found at https://www07.grants.gov/applicants/organization_registration.jsp. Step 3, in detail, can be
found at https://commons.era.nih.gov/commons/registration/registrationInstructions.jsp. After you have followed these steps,
submit paper applications to: Gladys M. Melendez, Grants Management
Officer/Specialist at the address noted earlier in this document (See
For Further Information and Additional Requirements Contact).
Dated: June 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-16091 Filed 6-27-11; 8:45 am]
BILLING CODE 4160-01-P
